Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
4 Patents
#136 in Vienna
#606 in Austria
Arsanis Biosciences Gmbh
Forward Citations = 23
22 inventors:
Arsanis Biosciences Gmbh
% Expired Patents = 25.0
EPO Patents = 4
Forward Citations = 23
Loading Chart...
Loading Chart...
22 inventors (with patents filed for the assignee):
Eszter Nagy (4 out of 42 patents)
Gábor Nagy (4 out of 11 patents)
Irina Mirkina (4 out of 7 patents)
4. Adriana Badarau (4 out of 7 patents)
5. Zoltán Magyarics (3 out of 4 patents)
6. Luis Guachalla (3 out of 6 patents)
7. Valéria Szijárto (2 out of 10 patents)
8. Jolanta Lukasiewicz (2 out of 7 patents)
9. Gerhild Zauner (2 out of 5 patents)
10. Bianka Prinz (1 out of 61 patents)
11. Valeria Szijárto (1 out of 2 patents)
12. Katharina Ramoni (1 out of 1 patent)
13. Tim Rollenske (1 out of 1 patent)
14. Hedda Wardemann (1 out of 1 patent)
15. Harald Rouha (1 out of 1 patent)
4 patents:
Company Overview
Arsanis Biosciences Gmbh is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases. The company's lead product candidate, ASN100, is being developed to prevent and treat Staphylococcus aureus infections.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arsanis Biosciences Gmbh. Retrieved from https://idiyas.com/company/arsanis-biosciences
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]